Aggregated price index with volume information
Summary:
- Digital Healthcare stocks down 0.4% on average while median return down -0.0% in a day
- Digital Healthcare stocks down 1.0% on average while median return down -0.8% in a week
- Digital Healthcare stocks up 1.6% on average while median return up 4.2% in a month
- When average return is significantly different from median return, this implies an asymmetry - composite return is driven by some outliners.
Aggregated price index (close) is based on equal weighted constituencies returns. Average short volume and average total volumes are averaged across all volume data among constituencies.
- 1M winners are : Winners for past month are $DRIO 10.0%, $BEAT 6.9%
- 1M losers are : Losers for past month are $TDOC -7.7%, $IRTC -14.1%
- 1W winners are : Winners for past week are $OPRX 6.8%, $TDOC 3.1%
- 1W losers are : Losers for past week are $BEAT -4.7%, $IRTC -10.7%
Correlation Analysis
Index correlation analysis
Correlation for the past month is 12.4%, for the past 3 months is 12.3%
In the past month for a 5 days rolling window, the highest corrrelation is 71.0%, the lowest correlation is -11.2%, the latest correlation is 15.1%
When a correlation deviated from the normal level and goes lower or even negative, it indicates some of stocks have deviated from the normal direction of the group. The deviation could reverse if long term level of correlation was at a higher level. It creates trading opportunities and deserves study whether the deviation is idiosyncratic or systematic.
Among pairwise correlation, the highest correlation is 56.8% between OPRX and TDOC
The lowest correlation is -28.1% between BEAT and IRTC
While iRhythm Technologies, Inc. ( NASDAQ:IRTC ) shareholders are probably generally happy, the stock hasn't had...
WALTHAM, Mass., July 25, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), the leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professional (HCPs) and patients, will hold a conference call on Thursday, August 8, 2024, at 4:30 p.m. Eastern Time to discuss its results for the second quarter period ended June 30, 2024. The financial results will be issued in a press release prior to the call. OptimizeRx manageme
Teladoc (TDOC) closed the most recent trading day at $9.30, moving +1.2% from the previous trading session.
OptimizeRx Micro Neighborhood® Targeting enables pharmaceutical brands to maintain and expand campaign scale nationwideWALTHAM, Mass., July 23, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced its continued commitment to partnering with pharmaceutical brands to navigate the rapidly changing landscape of state
Tech stocks got you down? While weeks of institutional tech stock outflows indicated souring sentiment, this week’s tech sector “crash” — though due for a correction, considering its current concentration — only trades a few points below recent highs. Whether the downward trend will continue remains to be seen, but I think there’s a higher likelihood of realignment among tech stocks to diversify away from the major names driving this year’s rally. To that end, picking tech stocks as moods and wi
SAN FRANCISCO, July 18, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the second quarter 2024 after the close of trading on Thursday, August 1, 2024. The company’s management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET. Interested parties may access a live
PURCHASE, NY, July 17, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, announced that it will release second quarter 2024 results on Wednesday, July 31, 2024, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day. Conference Call Details The conference call can be accessed by dialing 1-833-470-1428 for U.S. participants and using the access code # 453227. For
Key Insights Institutions' substantial holdings in Teladoc Health implies that they have significant influence over the...
The collaboration aims to support individuals under the age of 18 and their caregivers, addressing mental health conditions.
DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today a new contract with a national employer to provide its cardiometabolic solution with integrated support for GLP-1s to employees beginning in the third quarter of 2024.